These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9165531)
21. Overexpression of human IGF-II mRNA in the brain of transgenic mice modulates IGFBP-2 gene expression in the medulla oblongata. Reijnders CM; Koster JG; van Buul-Offers SC J Endocrinol; 2004 Sep; 182(3):445-55. PubMed ID: 15350186 [TBL] [Abstract][Full Text] [Related]
22. A novel approach to prepare insulin-loaded poly(lactic-co-glycolic acid) microcapsules and the protein stability study. Emami J; Hamishehkar H; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A J Pharm Sci; 2009 May; 98(5):1712-31. PubMed ID: 18855911 [TBL] [Abstract][Full Text] [Related]
24. Effect of cyclodextrins on the solubility and stability of a novel soft corticosteroid, loteprednol etabonate. Bodor N; Drustrup J; Wu W Pharmazie; 2000 Mar; 55(3):206-9. PubMed ID: 10756542 [TBL] [Abstract][Full Text] [Related]
25. Insight into the protein salting-in mechanism of arginine, magnesium chloride and ethylene glycol: Solvent interaction with aromatic solutes. Ura T; Arakawa T; Shiraki K Int J Biol Macromol; 2021 Oct; 188():670-677. PubMed ID: 34400229 [TBL] [Abstract][Full Text] [Related]
26. Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I. Skottner A; Clark RG; Fryklund L; Robinson IC Endocrinology; 1989 May; 124(5):2519-26. PubMed ID: 2707163 [TBL] [Abstract][Full Text] [Related]
27. The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution. Szenczi A; Kardos J; Medgyesi GA; Závodszky P Biologicals; 2006 Mar; 34(1):5-14. PubMed ID: 16168667 [TBL] [Abstract][Full Text] [Related]
29. Uptake of circulating insulin-like growth factors (IGFs) into cerebrospinal fluid appears to be independent of the IGF receptors as well as IGF-binding proteins. Pulford BE; Ishii DN Endocrinology; 2001 Jan; 142(1):213-20. PubMed ID: 11145584 [TBL] [Abstract][Full Text] [Related]
30. Chemical and thermal stability of insulin: effects of zinc and ligand binding to the insulin zinc-hexamer. Huus K; Havelund S; Olsen HB; van de Weert M; Frokjaer S Pharm Res; 2006 Nov; 23(11):2611-20. PubMed ID: 16969698 [TBL] [Abstract][Full Text] [Related]
31. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. Cleland JL; Jones AJ Pharm Res; 1996 Oct; 13(10):1464-75. PubMed ID: 8899836 [TBL] [Abstract][Full Text] [Related]
33. Relationship between preferential interaction of a protein in an aqueous mixed solvent and its solubility. Shulgin IL; Ruckenstein E Biophys Chem; 2005 Dec; 118(2-3):128-34. PubMed ID: 16260079 [TBL] [Abstract][Full Text] [Related]
34. pH and temperature-induced molten globule-like denatured states of equinatoxin II: a study by UV-melting, DSC, far- and near-UV CD spectroscopy, and ANS fluorescence. Poklar N; Lah J; Salobir M; Macek P; Vesnaver G Biochemistry; 1997 Nov; 36(47):14345-52. PubMed ID: 9398152 [TBL] [Abstract][Full Text] [Related]
35. An effective method for the separation of insulin-like growth factors 1 and 2 during the purification process. Tally M; Florell K; Enberg G Biosci Rep; 1988 Jun; 8(3):293-7. PubMed ID: 3207863 [TBL] [Abstract][Full Text] [Related]
36. Molecular mechanism of poly(vinyl alcohol) mediated prevention of aggregation and stabilization of insulin in nanoparticles. Rawat S; Gupta P; Kumar A; Garg P; Suri CR; Sahoo DK Mol Pharm; 2015 Apr; 12(4):1018-30. PubMed ID: 25644480 [TBL] [Abstract][Full Text] [Related]
37. Expression of biologically active human insulin-like growth factor-I following intramuscular injection of a formulated plasmid in rats. Alila H; Coleman M; Nitta H; French M; Anwer K; Liu Q; Meyer T; Wang J; Mumper R; Oubari D; Long S; Nordstrom J; Rolland A Hum Gene Ther; 1997 Oct; 8(15):1785-95. PubMed ID: 9358028 [TBL] [Abstract][Full Text] [Related]
38. Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties. Yamada T; Imai T; Ouchi K; Otagiri M; Hirayama F; Uekama K Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1264-9. PubMed ID: 10993223 [TBL] [Abstract][Full Text] [Related]
39. Mutants of human insulin-like growth factor I with reduced affinity for the type 1 insulin-like growth factor receptor. Cascieri MA; Chicchi GG; Applebaum J; Hayes NS; Green BG; Bayne ML Biochemistry; 1988 May; 27(9):3229-33. PubMed ID: 2839228 [TBL] [Abstract][Full Text] [Related]
40. Use of cyclodextrins as a cosmetic delivery system for fragrance materials: linalool and benzyl acetate. Numanoğlu U; Sen T; Tarimci N; Kartal M; Koo OM; Onyüksel H AAPS PharmSciTech; 2007 Oct; 8(4):E85. PubMed ID: 18181546 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]